Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer

Stopped early · Phase 2

Conditions studied: Ovarian Cancer, Primary Peritoneal Cavity Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of docetaxel in treating patients with recurrent or refractory ovarian or primary peritoneal cancer.

Key facts

Study ID

NCT00004037

Run by

Gynecologic Oncology Group

Starts

1998-06-01

Last updated by the study team

2013-04-11

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• CCOP - Greater Phoenix — Phoenix, Arizona, United States
• USC/Norris Comprehensive Cancer Center — Los Angeles, California, United States
• Jonsson Comprehensive Cancer Center, UCLA — Los Angeles, California, United States
• Chao Family Comprehensive Cancer Center — Orange, California, United States
• Women's Cancer Center — Palo Alto, California, United States
• University of Colorado Cancer Center — Denver, Colorado, United States
• Vincent T. Lombardi Cancer Research Center, Georgetown University — Washington D.C., District of Columbia, United States
• Walter Reed Army Medical Center — Washington D.C., District of Columbia, United States
• H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States
• Emory University Hospital - Atlanta — Atlanta, Georgia, United States
• CCOP - Atlanta Regional — Atlanta, Georgia, United States
• MBCCOP - Hawaii — Honolulu, Hawaii, United States
• Rush-Presbyterian-St. Luke's Medical Center — Chicago, Illinois, United States
• University of Chicago Cancer Research Center — Chicago, Illinois, United States
• CCOP - Evanston — Evanston, Illinois, United States
• CCOP - Central Illinois — Springfield, Illinois, United States
• Indiana University Cancer Center — Indianapolis, Indiana, United States
• University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States
• Albert B. Chandler Medical Center, University of Kentucky — Lexington, Kentucky, United States
• Johns Hopkins Oncology Center — Baltimore, Maryland, United States
• Medicine Branch — Bethesda, Maryland, United States
• Radiation Oncology Branch — Bethesda, Maryland, United States
• University of Massachusetts Memorial Medical Center — Worcester, Massachusetts, United States
• CCOP - Ann Arbor Regional — Ann Arbor, Michigan, United States
• University of Alabama Comprehensive Cancer Center — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.